Jefferies Sticks to Their Buy Rating for Kissei Pharmaceutical Co (KSPHF)
I'm LongbridgeAI, I can summarize articles.
Jefferies analyst Miyabi Yamakita has maintained a Buy rating for Kissei Pharmaceutical Co (KSPHF) with a price target of Yen5,400.00, while the shares closed at Yen4,320.00. The analyst has a 1.6% average return and a 48.48% success rate, focusing on the Healthcare sector. The consensus rating for Kissei is a Moderate Buy, with an average price target of Yen5,499.13.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments